Your browser doesn't support javascript.
loading
Evaluating the quality of evidence for diagnosing ischemic heart disease from verbal autopsy in Indonesia.
Zhang, Wenrong; Usman, Yuslely; Iriawan, Retno Widyastuti; Lusiana, Merry; Sha, Sha; Kelly, Matthew; Rao, Chalapati.
Afiliação
  • Zhang W; Department of Global Heath, Research School of Population Health, Australian National University, Canberra, ACT 2602, Australia. wenrong.zhang@anu.edu.au.
  • Usman Y; National Agency for Health Research and Development, Ministry of Health, Jakarta 10110, Indonesia.
  • Iriawan RW; National Agency for Health Research and Development, Ministry of Health, Jakarta 10110, Indonesia.
  • Lusiana M; National Agency for Health Research and Development, Ministry of Health, Jakarta 10110, Indonesia.
  • Sha S; Department of Global Heath, Research School of Population Health, Australian National University, Canberra, ACT 2602, Australia.
  • Kelly M; Department of Global Heath, Research School of Population Health, Australian National University, Canberra, ACT 2602, Australia.
  • Rao C; Department of Global Heath, Research School of Population Health, Australian National University, Canberra, ACT 2602, Australia.
World J Cardiol ; 11(10): 244-255, 2019 Oct 26.
Article em En | MEDLINE | ID: mdl-31754412
ABSTRACT

BACKGROUND:

Mortality and cause of death data are fundamental to health policy development. Civil Registration and Vital Statistics systems are the ideal data source, but the system is still under development in Indonesia. A national Sample Registration System (SRS) has provided nationally representative mortality data from 128 sub-districts since 2014. Verbal autopsy (VA) is used in the SRS to obtain causes of death. The quality of VA data must be evaluated as part of the SRS data quality assessment.

AIM:

To assess the strength of evidence used in the assignment of Ischaemic Heart Disease (IHD) as causes of death from VA.

METHODS:

The sample frame for this study is the 4,070 deaths that had IHD assigned as the underlying cause in the SRS 2016 database. From these, 400 cases were randomly selected. A data extraction form and data entry template were designed to collect relevant data about IHD from VA questionnaires. A standardised categorisation was designed to assess the strength of evidence used to infer IHD as a cause of death. A pilot test of 50 cases was carried out. IBM SPSS software was used in this study.

RESULTS:

Strong evidence of IHD as a cause of death was assigned based on surgery for coronary heart disease, chest pain and two out of sudden death, history of heart disease, medical diagnosis of heart disease, or terminal shortness of breath. More than half (53%) of the questionnaires contained strong evidence. For deaths outside health facilities, VA questionnaires for male deaths contained acceptable evidence in significantly higher proportions as compared to those for female deaths. (P < 0.001). Nearly half of all IHD deaths were concentrated in the 50-69 year age group (48.40%), and a further 36.10% were aged 70 years or more. Nearly two-thirds of the deceased were male (58.40%). Smoking behaviour was found in 44.11% of IHD deaths, but this figure was 73.82% among males.

CONCLUSION:

More than half of the VA questionnaires from the study sample were found to contain strong evidence to infer IHD as the cause of death. Results from medical records such as electrocardiograms, coronary angiographies, and load tests could have improved the strength of evidence and contributed to IHD cause of death diagnosis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article